Products

Brain WMH
Quantib BV
Neurology AI
Quantib Brain WMH, now part of DeepHealth's Neuro Suite, is an FDA-cleared AI tool for radiologists, quantifying brain atrophy and white matter hyperintensities on MRI to support the diagnosis and monitoring of neurodegenerative diseases.
Quantib Brain
Quantib BV
Neurology AI
Quantib Brain is an AI-powered software for quantitative MRI brain analysis, assisting radiologists and neurologists in detecting and monitoring neurodegenerative changes, brain atrophy, and white matter hyperintensities.
Quantib Prostate
Quantib BV
Oncology AI
Quantib Prostate is an FDA-cleared, AI-based software solution that streamlines and enhances the interpretation of multi-parametric MRI for prostate cancer diagnosis, offering advanced tools for segmentation, PI-RADS scoring, and standardized reporting.

See all 3 products →

About Quantib BV

Quantib BV is a healthcare AI company specializing in advanced radiology solutions designed to enhance the accuracy and efficiency of diagnostic pathways for physicians. The company leverages state-of-the-art artificial intelligence and machine learning techniques for the segmentation, classification, quantification, and visualization of medical images, particularly MRI and CT scans. Their software aims to automate and accelerate workflow, providing objective assessments that support more informed clinical decision-making and reduce interobserver variability in image interpretation.

Quantib’s portfolio includes FDA-cleared and CE-marked solutions primarily focused on neurodegeneration and prostate cancer. Key products like Quantib Prostate assist in the analysis of prostate MR images, generating AI-powered “heat maps” to highlight areas of concern and supporting structured reporting such as PI-RADS scoring. Quantib ND (Neurodegenerative) quantifies brain abnormalities on MRI, measuring volume loss (atrophy) in brain structures and detecting white matter hyperintensities, which are crucial for diagnosing and monitoring conditions like Alzheimer’s disease, Parkinson’s, Multiple Sclerosis, and dementia.

All of Quantib’s solutions are deployed through their proprietary AI Node platform, which ensures seamless integration into existing clinical workflows and facilitates the rapid regulatory clearance of future products. The company’s technology is developed in close collaboration with academic centers, such as Erasmus Medical Centre, ensuring a strong clinical foundation for their innovative AI applications.

Focus Areas

Medical image analysis AI radiology solutions neurodegeneration (dementia Alzheimer's Multiple Sclerosis Parkinson's) prostate cancer breast cancer lung disorders oncology bone structures

Business Intelligence

Key InvestorsHolland Capital, InnovationQuarter, Europa
PartnershipsUMC Utrecht (Joint Venture), Erasmus MC (spin-off, collaboration), GE Healthcare, Philips, Intrasense (for research, development, and distribution)
AcquisitionsAcquired by RadNet (January 2022), became part of DeepHealth (2023)
TechnologyQuantib AI Node platform (cloud-native, zero-footprint software, seamless workflow integration, rapid regulatory clearance)
FDA Clearances6+ cleared products (estimated)

What Physicians Need to Know

Neurodegeneration Solutions
Quantib specializes in AI-powered solutions for the analysis of brain MRI scans to detect and monitor neurodegenerative diseases such as dementia, Alzheimer's, and Multiple Sclerosis. Their Quantib ND (now DeepHealth Brain) software provides automatic segmentation, volumetric quantification of brain structures, and detection of white matter hyperintensities, comparing results with normative databases for objective assessment.
Prostate Cancer Diagnostics
Quantib offers AI radiology solutions for prostate cancer, notably Quantib Prostate (now DeepHealth Prostate). This software enhances MRI interpretation by providing AI-based segmentations, volumetry, PSA density calculation, PI-RADS scoring support, and bi-parametric heat map representations to highlight suspicious areas, aiding in faster and more accurate diagnosis.
Breast Cancer Detection
Quantib is involved in developing AI algorithms for breast MRI analysis, complementing broader breast cancer screening and detection initiatives within RadNet's DeepHealth division.
Advanced AI & Machine Learning
The company leverages state-of-the-art artificial intelligence, machine learning, and deep learning techniques to enable automatic analysis of medical imaging data, detecting subtle tissue changes sooner than manual interpretation.
Regulatory Compliance
Quantib's solutions are FDA cleared and CE marked, ensuring high standards of clinical reliability and regulatory compliance for use in various healthcare settings globally.
Seamless Workflow Integration
All Quantib solutions are deployed through their Quantib AI Node platform, which facilitates efficient workflow integration and rapid regulatory clearance of future products. It's designed for seamless integration with existing PACS systems.
Physician Tip

For physicians, Quantib BV's solutions, now largely integrated into DeepHealth, offer several key advantages. They significantly enhance diagnostic speed and accuracy by providing objective, quantitative measurements and automatically identifying abnormalities that might be missed by the naked eye. The software's ability to compare patient data with normative databases and track longitudinal changes is invaluable for monitoring disease progression, particularly in neurodegeneration. Furthermore, the intuitive interface and seamless integration with PACS systems streamline reporting workflows, reducing manual, time-consuming tasks. Physicians retain full control with editing capabilities, ensuring clinical oversight of AI-generated results. This combination of advanced AI, regulatory clearance, and user-centric design aims to boost diagnostic confidence and support more informed, multidisciplinary clinical decision-making.

Quantib's solutions are designed for seamless integration into existing radiology workflows. Their Quantib AI Node platform acts as a central hub, enabling efficient data transfer via DICOM connections to and from Picture Archiving and Communication Systems (PACS). The solutions are vendor-independent, allowing for flexible deployment within diverse clinical environments.

Products by Quantib BV

3 products in the directory

Brain WMH
Quantib BV
Neurology AI
Quantib Brain WMH, now part of DeepHealth's Neuro Suite, is an FDA-cleared AI tool for radiologists, quantifying brain atrophy and white matter hyperintensities on MRI to support the diagnosis and monitoring of neurodegenerative diseases.
Quantib Brain
Quantib BV
Neurology AI
Quantib Brain is an AI-powered software for quantitative MRI brain analysis, assisting radiologists and neurologists in detecting and monitoring neurodegenerative changes, brain atrophy, and white matter hyperintensities.
Quantib Prostate
Quantib BV
Oncology AI
Quantib Prostate is an FDA-cleared, AI-based software solution that streamlines and enhances the interpretation of multi-parametric MRI for prostate cancer diagnosis, offering advanced tools for segmentation, PI-RADS scoring, and standardized reporting.

What the Web Says

Quantib BV, now part of DeepHealth (a subsidiary of RadNet), specializes in AI-powered medical imaging software for radiologists, particularly for brain and prostate analysis. The company's products, such as Quantib ND and Quantib Prostate, aim to enhance diagnostic accuracy and efficiency by detecting subtle changes in tissue. While there are positive testimonials from medical professionals regarding the product's value in clinical decision-making, there is limited information available on employer reviews from platforms like Glassdoor or direct employee feedback on company culture.

Overall: Positive

Strengths

  • Provides fast, objective, and accurate reports for radiologists.
  • Enables constructive multidisciplinary meetings and efficient decision-making.
  • Delivers quantified information for dementia and objective tracking of disease progression for MS patients.
  • Enhances diagnostic accuracy and supports clinical research.
  • Integrates with existing radiology workflows, minimizing disruption and maximizing efficiency.
  • Uses advanced machine learning techniques to detect abnormalities sooner than possible with the naked eye.

Limitations

  • Limited publicly available employee reviews for company culture and employer experience.
  • Some general AI radiology tools on Reddit have received mixed reviews regarding actual time-saving in practice.
  • The software may initially seem complex to learn for some users.
  • Pricing information is not readily available in public reviews.
  • One Reddit user noted that AI reports were not always similar to their own, potentially increasing review time.

Based on reviews from: FeaturedCustomers, DeepHealth, Trustpilot, VirtualExpo, SoftwareWorld, Reddit, G2, Indeed.com, Capterra, Comparably

Last updated: 2026-07-19

Videos

News, demos, and interviews about Quantib BV.

Loading videos...

Videos load interactively. If none appear, search YouTube for Quantib BV →

View all on YouTube

Press & Coverage

Holland Capital
Quantib has been acquired by RadNet
Quantib, a leading radiology AI company focusing on clinical solutions for prostate cancer, breast cancer, and neurodegeneration, was acquired by RadNet, Inc. in January 2022. Quantib's management team will remain with the company, which aims to enable more accurate and efficient clinical decision-making for 10 million patients by 2030.
2022-01
Nasdaq
RadNet Completes the acquisitions of Aidence Holding B.V. and Quantib B.V. to Address Opportunities in Lung and Prostate Cancer Diagnosis and Screening with Artificial Intelligence
RadNet, Inc. announced the acquisition of Quantib B.V. in January 2022, expanding its AI division to include solutions for prostate and brain MRI, alongside Aidence for lung and chest CT scanning. Quantib's solutions already have FDA 510(k) clearance and CE mark.
2022-01
GlobeNewswire
RadNet Artificial Intelligence Subsidiaries, DeepHealth and Quantib, Obtain FDA Clearance for Mammography and Prostate AI Tools
In May 2022, RadNet announced that its subsidiaries, DeepHealth and Quantib, received FDA clearances for their DeepHealth Saige-DXu2122 mammography and Quantibu00ae Prostate 2.0 MRI artificial intelligence algorithms. Quantib's solutions are deployed through its AI Node platform, enabling seamless workflow integration.
2022-05
Imaging Technology News
Quantib Receives FDA Clearance for First-to-Market Prostate Solution
Quantib received FDA clearance for its prostate solution in October 2020, a zero-footprint software providing a comprehensive workflow for enhanced assessments and fast processing. The solution aims to improve prostate cancer diagnoses by offering tools like image-based PSA density calculation and bi-parametric heat maps.
2020-10
AuntMinnie
Quantib gets FDA nod for AI integration platform
Quantib received U.S. FDA clearance for its AI workflow integration platform, Quantib AI Node, in July 2020. This platform allows radiologists to integrate Quantib's AI algorithms into their daily workflow and is the fifth FDA clearance for the company.
2020-07
Diagnostic Imaging
Quantib Secures FDA Clearance for AI Workflow Platform
Quantib secured 510(k) clearance from the U.S. FDA in July 2020 for its AI workflow integration platform, Quantib AI Node, designed to help radiologists process CT and MRI scans faster. The company also opened a New York office to bring its solution closer to radiologists in the U.S.
2020-07
Medimaging.net
AI-Powered Radiology Software Receives FDA Clearance
Quantib Neurodegenerative (ND) software, which assists radiologists in reading MRI brain scans by measuring brain atrophy and detecting white matter hyperintensities, received FDA clearance for distribution in the U.S. in January 2019. This software uses advanced machine learning to detect subtle tissue changes.
2019-01
InnovationQuarter
Medical Artificial Intelligence company Quantib receives capital injection of u20ac 4.5 million
Quantib announced in November 2017 that it secured u20ac4.5 million ($5.4 million) in funding, led by Holland Venture and InnovationQuarter. This investment supports Quantib's international scale-up ambitions and the development of new machine learning applications for medical imaging analyses.
2017-11

Frequently Asked Questions

Quantib, now part of DeepHealth, provides AI-powered solutions for medical image analysis. Key offerings include DeepHealth Brain (formerly Quantib ND) for neurodegeneration, which quantifies brain atrophy and white matter hyperintensities, and DeepHealth Prostate (formerly Quantib Prostate) for prostate cancer detection and management. DeepHealth also offers solutions for breast cancer (Breast Suite) and lung disorders (Chest Suite), building on Quantib's earlier development in these areas.
Quantib ND, now DeepHealth Brain, uses machine learning to automatically measure brain atrophy and detect white matter hyperintensities from MRI scans. This provides quantitative data on brain structure volumes, which can be compared to normative databases, assisting physicians in assessing and tracking conditions like dementia, Alzheimer's, and Multiple Sclerosis over time.
Quantib Prostate, now DeepHealth Prostate, offers an AI-based software solution to enhance prostate cancer detection and streamline MRI reporting workflows. It includes features like AI-driven prostate and sub-region segmentation, automated PSA density calculation, PI-RADS scoring support, and standardized reporting to improve diagnostic accuracy and efficiency for radiologists and urologists.
Yes, Quantib's medical image analysis solutions, including those for neurodegeneration and prostate cancer, have received both FDA clearance in the United States and CE marking in Europe. The company adheres to regulatory requirements such as the Quality System (QS) regulation (21 CFR Part 820) and the Unique Device Identification System (UDI Rule) for medical devices.
The pricing for Quantib's AI radiology solutions, such as Quantib Prostate, is custom and depends on the specific features and organizational needs. While detailed third-party integration information is limited, customer support is available via email/help desk and phone, complemented by a knowledge base for users.
Quantib BV was acquired by RadNet, Inc. in 2022 and subsequently became part of DeepHealth, a wholly-owned subsidiary of RadNet, in 2023. This integration provides strong backing and stability within a leading diagnostic imaging provider. Historically, Quantib has also formed partnerships with industry players like GE Healthcare, Philips, and Intrasense for development and distribution.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

TalkToMedi is a Canadian healthcare AI company that has developed a clinical-grade voice AI platform called MEDI. This platform is designed to automate patient communication and administrative tasks for medical clinics, including family medicine, specialty clinics, allied health, and physiotherapy. MEDI handles high-volume patient calls, automating appointment inquiries, booking, rescheduling, and cancellations based on the […]

Menaela is an AI-first practice management system designed for solo practitioners, small private clinics, and clinic owners. It integrates patient communication, scheduling, CRM, and medical documentation into a single platform, aiming to replace multiple disconnected tools and bots. The system features an AI practice manager that understands natural-language requests, utilizes real clinic data, and performs […]

Avie is operated by AVIE TECNOLOGIA LTDA, headquartered in Santo André, São Paulo, Brazil. Avie provides WhatsApp reception in Brazilian Portuguese, appointment scheduling, rescheduling and cancellations through Google Calendar or Feegow, clinic CRM, follow-up messages and an online booking website. Clinic staff can review conversations and take over when human support is needed. Clinic CRM […]

Saile is a physician-founded healthcare technology company that addresses critical inefficiencies in healthcare staffing and credentialing. Their AI-powered platform acts as a “universal credential passport” for physicians, centralizing and managing all medical licenses, certifications, and CME credits in one secure, portable vault. This system aims to significantly reduce the administrative burden and delays associated with […]

Data Capture Experts (DCE) is an Australian-based healthcare AI company that is at the forefront of digital health transformation. They specialize in developing and implementing digital health platforms that integrate data, technology, and human-centered design to create intuitive and connected healthcare systems. Their flagship platform, DC2Vue, is designed to go beyond traditional Electronic Medical Records […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.